Northwest Medical Isotopes Gains NRC Approval

May 9th, 2018

(from the Corvallis Gazette-Times, May 9, 2018, click here for the full story)

A small Corvallis company took a big step forward this week when it won approval from the Nuclear Regulatory Commission to build a processing plant for radioactive medical isotopes.

“We’ve passed a major milestone that we’ve been anticipating for a couple of years now,” CEO Nick Fowler said.

Fowler said the company hopes to break ground within the next four months and have the plant up and running 18 to 24 months after that. The 60,000-square-foot facility will employ about 80 people.

The company, founded in 2010 to commercialize a new technology developed at Oregon State University, aims to become a major U.S. supplier of molybdenum-99, a radioactive isotope used in cardiac stress tests, bone scans and other medical procedures.